CornerCap Investment Counsel »

Allogene Therapeutics shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $195k 61k 3.21

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Caxton Associates
Nordea Investment Management Ab
Charles Schwab Investment Management

View all funds holding Allogene Therapeutics